Pionyr Immunotherapeutics Collaborates with Lonza to Support their Oncology Product Development. The collaboration aims to bring Pionyr’s third pipeline development candidate for a novel Myeloid Tuning TM target in to clinical development; Lonza to provide cell line development, process development, drug substance and drug product manufacturing for ...
Pionyr Immunotherapeutics discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.